I Read The News Today Oh Boy! 7-May-2019 & May Updates

Tuesday, May 07 2019 by

Morning all!

First off all, I have posted my Monthly Recap for May here - Covering all my purchases and sales in the month of April.

Secondly, I have posted my Parity PEG Price Reports for May here (free sign up required to access) - Covering 20 stocks updated in the month of April.

Onto this morning...

4imprint ( 4imprint (LON:FOUR) ) – 2580p – £724m – PER 22.1

AGM Statement – In a strong position to hit £1bn in Revenue by 2022, first 4 months of 2019 strong with Revenue up 16%, early in the year but Board confident of delivering on FY expectations.

Looks fairly valued here to me.

Begbies Traynor ( Begbies Traynor (LON:BEG) ) – 60p – £69m – PER 11.5

Trading Update For The 12 Months To End April 2019 – FY To be comfortably ahead, entering the new year with a strong Order book and favourable market conditions.

Still think there's value here (perhaps a lot) but the poor ROCE and Op margin hold me back.

Costain ( Costain (LON:COST) ) – 325p – £350m – PER 8

AGM Statement – In-line.

Looks like there's value here – Low growth and low margin offset by Net Cash and a decent Yield.

Empresaria ( Empresaria (LON:EMR) ) – 74p – £36m – PER 6

AGM Statement – Om course to meet FY expectations (reliant on H2 weightings).

Even on a PER of 6 still doesn't tempt me - Net Debt is high, Operating margin is low, (EPS) growth is forecast <2% per year and now, H2 weighting too!

Kape Technologies ( Kape Technologies (LON:KAPE) ) – 90p – £130m – PER 14.9

AGM Statement – Strong start to the year, trading in-line, subscriber number growth exceeding expectations.

I am Long here and this seems good enough reason to remain so for now (based on the expectations (Broker forecasts) I have access to).

SDL ( SDL (LON:SDL) ) – 532p – £482m – PER 17.7

AGM Statement –…

Unlock this article instantly by logging into your account

Don’t have an account? Register for free and we’ll get out your way


As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. The author may own shares in any companies discussed, all opinions are his/her own & are general/impersonal. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.

Do you like this Post?
15 thumbs up
0 thumbs down
Share this post with friends

4imprint Group plc is a direct marketer of products in the United States, Canada, the United Kingdom and Ireland. The Company supplies products under the brand name 4imprint. The Company sells a range of promotional products, which are purchased by a range of individuals within various types and sizes of businesses and organizations. These products have a range of uses as an integral part of sales and marketing activities; recruitment and recognition schemes; health and safety programs; and other initiatives to make a connection between the customer's organization and the recipient. Its promotional products consist of basic giveaways, such as pens, bags and drinkware to more exclusive products, such as embroidered clothing, business gifts and full color trade show displays. The Company's subsidiaries, 4imprint Inc. and 4imprint Direct Marketing Limited, are engaged in direct marketing activities. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

Begbies Traynor Group plc is a business recovery and property services consultancy. The Company's segments include insolvency and restructuring, and property. It provides services from a network of the United Kingdom locations through two operating divisions: Begbies Traynor and Eddisons. Begbies Traynor is an independent business recovery practice that handles corporate appointments, serving the mid-market and smaller companies. It provides insolvency, restructuring and consultancy services to businesses, their professional advisors and financial institutions. Eddisons is a national firm of chartered surveyors, delivering transactional and advisory services to owners and occupiers of commercial property, investors and financial institutions. It provides professional services, such as business rescue options, advisory options, forensic accounting and investigations, corporate and commercial finance, personal insolvency solutions and services to banking, legal and accounting sectors. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

Costain Group PLC is a technology-based engineering solutions provider. The Company offers consulting, project delivery, and operations and maintenance services. The Company operates through two segments: Natural Resources and Infrastructure plus Alcaidesa in Spain. The Infrastructure segment operates in the highways, rail and nuclear markets. The Natural Resources segment includes the Company's activities in water, power, and oil & gas markets. The Company offers a range of services, including advisory and concept development, specialist design, program management, project delivery, technology integration, and asset optimization and support. The Company offers services across whole life cycle of its customers assets in energy, water and transportation business areas focused on the United Kingdom market. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

  Is LON:FOUR fundamentally strong or weak? Find out More »

8 Posts on this Thread show/hide all

MrContrarian 7th May 1 of 8

My morning smallcap tweet: Brown trousers for PurpleBricks.

Bidstack (LON:BIDS), Begbies Traynor (LON:BEG), ImmuPharma (LON:IMM), Purplebricks (LON:PURP)

Bidstack Group (BIDS) £5m placing at 12.5p, a 19% discount. Placing "gives us the financial resources to capitalise on our strong current position."
Begbies Traynor (BEG) guides FY rev and profit comfortably ahead of market expectations thanks to a number of successful fee realisations combined with continuing strong performance from both operating divisions.
Immupharma (IMM) delays Managed Access Program for Lupuzor while talks continue with potential corporate partners as well as consulting with regulatory advisors on potential pathways to market.
Purplebricks Group (PURP) Founder & CEO resigns. Immediately reverse some of his plans. Exits Australia, blames execution errors and challenging mkt. Rows back on US - "materially cut investment in marketing and other overheads to reduce expenditure to sustainable levels and begun a strategic review." CEO is thanked.

| Link | Share
andrea34l 7th May 2 of 8

On the face of it, things sound rosy enough with the Kape Technologies (LON:KAPE) figures mentioned... but when I looked at the finals previously I was put off by low revenue growth and the low ROCE and margin figures on Stocko. Some of the positive results seem to be a conversion of their existing business model rather than new business, to provide a more secure revenue stream rather than, necessarily, additional revenue.

There is a Q4 update from Distil (LON:DIS) which looks a bit scary on the face of it.... "revenues and volumes were in line with our expectations, being 33% and 32% lower respectively, reflecting the additional stock build by our distributors during the third quarter", though management claim it is part of their strategy being "a result of the earlier phasing of our promotional activities, the sales benefits of which were seen in the third quarter, which is our major trading period".

There is an update from Kromek (LON:KMK) stating revenue growth for the full year 2018/19 and EBITDA profit will be in-line, and with a confident outlook; the share are reacting moderately positively. I hold.

There is a positive update from Victoria (LON:VCP) stating results will be in line, positive lfl of 3%, increased margin of 100bps with them forecasting a similar margin update in 2020 as well as a lot of cashflow to bring down debt.

There is a 500k buy of shares in Xpediator (LON:XPD) by the CEOs family, taking their interest up to 26.4%, plus 0.?% held by the CEO himself. I wonder if he'll eventually take it private....?

The market quite likes the acquisition of Ecopac by Macfarlane (LON:MACF) although I do wonder if they have overpaid a little, with a maximum cash consideration of £3.9 million (including an earn-out of £0.8m) when in 2017-18 Ecopac generated sales of £6.0 million and pre-tax profits of £0.5 million.

The thing I don't like with the announcement from Begbies Traynor (LON:BEG) is that there are no numbers in it!!! What does "strong" mean? (Presumably better than 'solid'). The fee realisations are adhoc rather than predictable income, so won't necessarily be repeated, at least in the same magnitude. I think I'd have to wait for the results.... but I agree that the ROCE and margin are poor, and in fact I wonder how on earth Stocko comes up with a Quality score of 71 for them!

| Link | Share
wilkonz 7th May 3 of 8

Costain (LON:COST) puzzles me. The metrics look good but it's currently trading 15% below its 200 day MA and heading down steadily. There's clearly something about this company that the market doesn't like. But it's hard to identify exactly what that negative factor is.

| Link | Share | 1 reply
andrea34l 7th May 4 of 8

In reply to post #474076

I had a quick look at Costain (LON:COST) and, in the last results, operating profit was up only 7% and revenue was down a thumping 14%! Operating margins are low, but this is the nature of the business... though unfortunately means that if one project goes wrong then profits can be severely affected. I couldn't invest in this until (1) I see a return to revenue growth and (2) the HORRENDOUS chart, which has been in decline for almost 12 months, turns positive.

| Link | Share | 2 replies
wilkonz 7th May 5 of 8

In reply to post #474081

Thanks Andrea..

| Link | Share
matylda 7th May 6 of 8


Great comment this morning guys, thanks.

Costain (LON:COST) - For me, if you take the Net Cash, the Yield (5% or so), the forecast EPS growth of 10% or so next year and the year after, looks like a decent income play (if you accept that any knock on that low margin will not hurt too much, I would not expect it to impact the ability to pay the Dividend (having so much Cash)) with the potential for 20% or so upside in the SP (bringing the Yield to 4% or so).

Distil (LON:DIS) - Too small a Market Cap for me but a quick skim of the RNS and fundamentals and it doesn't excite me much at all.

Kape Technologies (LON:KAPE) - Will, price action depending, probably look to hold here through to actuals - EPS forecasts still look to be on target (and they're 30%+ in 2019E and again in 2020E). True enough the low ROCE and Op Margin is a concern. However, I reckon the Op Margin is slightly out considering say £50m Revenue and £10m PBT.

Kromek (LON:KMK) - Need to see a profit (or at least firm confirmation of it) here first before considering.

Xpediator (LON:XPD) - Tempted to get back in here, it's one of 7 on my Watch List, perhaps concerned a little about import/export services but I suppose they would do well regardless of B***** whatever the outcome, especially companies that have already said so.

Macfarlane (LON:MACF) - Need to look at this, just noticed an updated Broker note, looks like EPS is lifted 2% (2019E) and 3% (2020E).

Begbies Traynor (LON:BEG) - Yes, Op margin and ROCE and "lumpy" or at least unpredictable.

Blog: Briefed Up
| Link | Share | 1 reply
andrea34l 7th May 7 of 8

In reply to post #474126

Please can you provide the updated broker figures for Macfarlane (LON:MACF) Matylda?

| Link | Share | 1 reply
matylda 7th May 8 of 8

In reply to post #474196

You know Andrea, I apologise but I just don't feel comfortable doing ad-hoc requests - Research Tree is a service I pay for and though I feel comfortable including the information in updates, comments, reports, etc. unprompted - I would feel quite awful about responding to an ad-hoc request, at what point would I stop and potentially destroy an otherwise excellent service that Research Tree provides :(

Hope you understand.

Blog: Briefed Up
| Link | Share

Please subscribe to submit a comment

 Are LON:FOUR's fundamentals sound as an investment? Find out More »

Stock Picking Tutorial Centre

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis